Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. (Q39135703)
Jump to navigation
Jump to search
scientific article published on 28 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. |
scientific article published on 28 October 2016 |
Statements
1 reference
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. (English)
1 reference
Sareetha Kailayangiri
1 reference
Christian Spurny
1 reference
Silke Jamitzky
1 reference
Sonja Schelhaas
1 reference
Andreas H Jacobs
1 reference
Constanze Wiek
1 reference
Katharina Roellecke
1 reference
Helmut Hanenberg
1 reference
Susann Pankratz
1 reference
Jutta Meltzer
1 reference
Nicole Farwick
1 reference
Lea Greune
1 reference
Maike Fluegge
1 reference
Claudia Rossig
1 reference
28 October 2016
1 reference
1 reference
e1250050
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference